全文获取类型
收费全文 | 3416篇 |
免费 | 183篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 24篇 |
儿科学 | 111篇 |
妇产科学 | 38篇 |
基础医学 | 295篇 |
口腔科学 | 108篇 |
临床医学 | 272篇 |
内科学 | 834篇 |
皮肤病学 | 46篇 |
神经病学 | 169篇 |
特种医学 | 158篇 |
外国民族医学 | 1篇 |
外科学 | 686篇 |
综合类 | 80篇 |
一般理论 | 1篇 |
预防医学 | 279篇 |
眼科学 | 85篇 |
药学 | 230篇 |
中国医学 | 16篇 |
肿瘤学 | 184篇 |
出版年
2023年 | 30篇 |
2022年 | 42篇 |
2021年 | 117篇 |
2020年 | 60篇 |
2019年 | 85篇 |
2018年 | 111篇 |
2017年 | 67篇 |
2016年 | 72篇 |
2015年 | 61篇 |
2014年 | 136篇 |
2013年 | 166篇 |
2012年 | 198篇 |
2011年 | 264篇 |
2010年 | 151篇 |
2009年 | 144篇 |
2008年 | 182篇 |
2007年 | 186篇 |
2006年 | 187篇 |
2005年 | 181篇 |
2004年 | 150篇 |
2003年 | 157篇 |
2002年 | 152篇 |
2001年 | 71篇 |
2000年 | 75篇 |
1999年 | 51篇 |
1998年 | 23篇 |
1997年 | 10篇 |
1996年 | 19篇 |
1995年 | 18篇 |
1994年 | 17篇 |
1993年 | 14篇 |
1992年 | 33篇 |
1991年 | 37篇 |
1990年 | 36篇 |
1989年 | 28篇 |
1988年 | 31篇 |
1987年 | 35篇 |
1986年 | 26篇 |
1985年 | 27篇 |
1984年 | 14篇 |
1983年 | 10篇 |
1981年 | 8篇 |
1979年 | 15篇 |
1978年 | 13篇 |
1973年 | 11篇 |
1970年 | 9篇 |
1969年 | 13篇 |
1968年 | 8篇 |
1967年 | 7篇 |
1966年 | 9篇 |
排序方式: 共有3617条查询结果,搜索用时 609 毫秒
121.
122.
123.
Hitesh Lal Yashwant Singh Tanwar Atin Jaiswal Satya Prakash Singh Masood Habib 《中华创伤杂志(英文版)》2014,17(4):242-245
Scapulothoracic dissociation is a rare and complex injury pattern with varied presentation.Here we describe a case of a 32-year-old male who presented with scapulothoracic dissociation associated with brachial plexus injury,along with scapholunate dissociation.We also propose an injury mechanism that might link the two injury patterns,suggesting that the association might be more than by chance.The patient was managed according to established trauma care and resuscitation protocols followed by open reduction and internal fixation of the clavicle fracture,and fixation of scapholunate dissociation and had a successful outcome at follow-up. 相似文献
124.
Wondwossen G. Tekle Saqib A. Chaudry Ameer E. Hassan Habib Qaiser Mikayel Grigoryan Gustavo J. Rodriguez Adnan I. Qureshi 《Neurocritical care》2014,20(3):399-405
Background
There is controversy whether asymptomatic vasospasm in other arteries should be concurrently treated (global treatment) in patients receiving targeted endovascular treatment [percutaneous-transluminal-angioplasty (PTA) and/or intra-arterial (IA) vasodilators] for focal symptomatic vasospasm.Objective
To determine the rates of occurrence of new symptomatic vasospasm in previously asymptomatic arterial distributions among patients with aneurysmal subarachnoid hemorrhage (SAH) who underwent targeted endovascular treatment for focal symptomatic vasospasm.Methods
We identified all patients with SAH who had received targeted endovascular treatment during a 4-year period. We ascertained any new occurrence of symptomatic vasosopasm requiring endovascular treatment in previously unaffected (and untreated) arterial distributions within the same hospitalization. Blinded reviewers quantitatively graded angiographic vasospasm (<25, 26–49, ≥50 %) in all major arteries for each patient at the time of targeted treatment.Results
Of the 41 patients who received targeted endovascular treatment (PTA in 41 % and vasodilators in 59 %), 11 (27 %) developed new symptomatic vasospasm in previously asymptomatic vascular distributions requiring endovascular treatment. Moderate severity of angiographic vasospasm in asymptomatic arteries at the time of targeted treatment tended to predict the occurrence of new symptomatic vasospasm. The rate of death and disability at discharge [modified Rankin scale (mRS) of 3–6] was 82 % (9/11) among those who developed a new episode of symptomatic vasospasm compared with 70 % (21/30) in those who did not (P = 0.58).Conclusions
High risk of new occurrence of ischemic symptoms in previously asymptomatic (and untreated) arterial distributions among patients receiving targeted treatment should be recognized. Further studies should evaluate the benefit of performing global endovascular treatment during the initial targeted endovascular treatment session. 相似文献125.
M.H. Houman N. Bel Feki 《La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne》2014
Although the precise pathogenesis and etiology of Behçet's disease (BD) still remains unknown, current evidence suggests that inflammatory reaction in BD arises from disruption of homeostasis in genetically susceptible individuals, resulting in altered innate and adaptive immunity responses, pathogenic T cell activation in the peripheral blood, and in inflammatory sites. Association with HLA-B51 is known as the strongest genetic susceptibility factor for BD. Recent GWAS (genome-wide association studies) have confirmed this relationship, and reported new susceptibility genes (IL-10, IL-23R, IL-12RB2) for the disease. A triggering infectious agent could operate through molecular mimicry, and the disease could subsequently be perpetuated by an abnormal immune response to an auto-antigen in the absence of ongoing infection. Several potential bacteria have been investigated but the most commonly implicated microorganism is Streptococcus sanguis. Recent data have showed that the T cell homeostasis perturbation consisted mainly of Th1 and Th17 expansions, while regulatory T cell response was suppressed. Cytokine such as IL-17, IL-23 and IL-21 play a significant role in the pathogenesis of BD. Inflammatory cells within BD inflammatory lesions include mostly neutrophils, CD4+ T cells, and cytotoxic cells. Lastly, endothelium dysfunction has been clearly established. This improved understanding of the pathophysiology of BD will certainly lead to the development of new therapeutic agents, potentially more effective than current therapy. In this review, we have studied the etiopathogenesis of BD in the light of recent advances. 相似文献
126.
The objective of this study was to evaluate the effect of intra-articular corticosteroid injection (IACI) of methylprednisolone acetate (MPA) on the hypothalamic–pituitary–adrenal (HPA) axis in patients with osteoarthritis of the knee. Patients with symptomatic osteoarthritis of the knee who failed to respond to nonsteroidal anti-inflammatory medications and physical therapy were randomized between group 1 and group 2. Group 1 patients had an IACI of 80 mg of MPA at the knee joint and group 2 patients had an intra-articular injection (IAI) of 6 ml (60 mg) of sodium hyaluronate (control group). Immediately prior to the IAI and on weeks 1, 2, 3, 4, and 8 following IAI, patients from both groups underwent a low-dose (1 μg) adrenocorticotropin hormone (ACTH) stimulation test. Demographic, clinical, laboratory, and radiologic variables were documented in all patients. Both criteria of <7 μg/dl increase in the serum cortisol level and absolute levels of <18 μg/dl 30 min following the ACTH stimulation test were used to define secondary adrenal insufficiency (SAI). Twenty patients were randomized in each group. In group 1, 25 % of patients had SAI vs. none in group 2 (p?=?0.0471). The earliest SAI was observed at week 2, and latest SAI was observed at week 4. SAI was observed at one time point, two consecutive time points, or two separate time points in the same patient. There was no correlation between SAI and any of the demographic, clinical, or laboratory variables. An IACI of 80 mg MPA at the knee joint induced a transient SAI in 25 % of the patients, an effect that was observed between week 2 and week 4 following the IACI. 相似文献
127.
Taghreed Shams MBBS FRCSC Belal Firwana MD Farida Habib PhD Abeer Alshahrani MBBS Badria AlNouh MBBS Mohammad Hassan Murad MD Mazen Ferwana MD 《Journal of general internal medicine》2014,29(1):204-213
Background
Hot flashes are the most commonly reported vasomotor symptom during the peri- and early post-menopausal period.Objectives
To systematically review, appraise and summarize the evidence of the impact of different SSRIs on peri-menopausal hot flashes in healthy women in randomized, controlled trials.Methods
A comprehensive literature search was conducted of MEDLINE?, EMBASE, the Cochrane Central Register of Controlled Trials, Web of Science and Scopus through March 2013. Two independent reviewers selected studies and extracted data. Random effects meta-analysis was used to pool outcomes across studies, and Bayesian mixed treatment methods were used to rank SSRIs in terms of effectiveness.Results
We included a total of 11 randomized controlled trials with good methodological quality enrolling 2,069 menopausal and post-menopausal women (follow-up 1–9 months, mean age 36–76 years, mean time since menopause 2.3–6.6 years). Compared with placebo, SSRIs were associated with a statistically significant decrease in hot flash frequency (difference in means ?0.93; 95 % CI ?1.46 to ?0.37; I2 = 21 %) and severity assessed by various scales (standardized difference in means ?0.34; 95 % CI ?0.59 to ?0.10; I2 = 47 %). Adverse events did not differ from placebo. Mixed treatment comparison analysis demonstrated the superiority of escitalopram compared to other SSRIs in terms of efficacy.Conclusion
SSRI use is associated with modest improvement in the severity and frequency of hot flashes but can also be associated with the typical profile of SSRI adverse effects. 相似文献128.
Maha Hoteit Asma Arabi Robert Habib Rami Mahfouz Rafic Baddoura Georges Halaby Ghada El-Hajj Fuleihan 《Metabolism: clinical and experimental》2014
Objective
Variants of estrogen receptor α (ERα) have been associated with obesity, dyslipidemia, diabetes and blood pressure. The Middle East registers some of the highest rate of metabolic syndrome worldwide. The aim of this study is to investigate the relationship between metabolic syndrome, a clustered combination of these metabolic factors, and polymorphisms PvuII and XbaI of ERα in Lebanese Caucasian elderly overweight subjects.Material/Methods
250 Caucasian Lebanese unrelated elderly men and women, median age 71 years, were studied. ERα intronic polymorphisms variants, PvuII and XbaI diplotypes and genotypes, were examined. Associations with metabolic syndrome, defined by the American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI), and its components, namely high density lipoprotein (HDL), fasting glucose levels, blood pressure, and waist circumference were evaluated in regression models.Results
ER α diplotypes and genotypes distributions were similar between participants with and without metabolic syndrome, in the overall group of subjects, and by gender. No consistent associations between the diplotypes and genotypes tested and metabolic syndrome, or its components, could be detected.Conclusions
Genetic variants in ERα were not associated with metabolic syndrome or its components, in a group of 250 Lebanese Caucasian elderly participants, a group with a high prevalence of metabolic syndrome. 相似文献129.
Brain networks disconnection in early multiple sclerosis cognitive deficits: An anatomofunctional study
下载免费PDF全文
![点击此处可从《Human brain mapping》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Céline Louapre Vincent Perlbarg Daniel García‐Lorenzo Marika Urbanski Habib Benali Rana Assouad Damien Galanaud Léorah Freeman Benedetta Bodini Caroline Papeix Ayman Tourbah Catherine Lubetzki Bruno Stankoff 《Human brain mapping》2014,35(9):4706-4717
Severe cognitive impairment involving multiple cognitive domains can occur early during the course of multiple sclerosis (MS). We investigated resting state functional connectivity changes in large‐scale brain networks and related structural damage underlying cognitive dysfunction in patients with early MS. Patients with relapsing MS (3–5 years disease duration) were prospectively assigned to two groups based on a standardized neuropsychological evaluation: (1) cognitively impaired group (CI group, n = 15), with abnormal performances in at least 3 tests; (2) cognitively preserved group (CP group, n = 20) with normal performances in all tests. Patients and age‐matched healthy controls underwent a multimodal 3T magnetic resonance imaging (MRI) including anatomical T1 and T2 images, diffusion imaging and resting state functional MRI. Structural MRI analysis revealed that CI patients had a higher white matter lesion load compared to CP and a more severe atrophy in gray matter regions highly connected to networks involved in cognition. Functional connectivity measured by integration was increased in CP patients versus controls in attentional networks (ATT), while integration was decreased in CI patients compared to CP both in the default mode network (DMN) and ATT. An anatomofunctional study within the DMN revealed that functional connectivity was mostly altered between the medial prefrontal cortex (MPFC) and the posterior cingulate cortex (PCC) in CI patients compared to CP and controls. In a multilinear regression model, functional correlation between MPFC and PCC was best predicted by PCC atrophy. Disconnection in the DMN and ATT networks may deprive the brain of compensatory mechanisms required to face widespread structural damage. Hum Brain Mapp 35:4706–4717, 2014. © 2014 Wiley Periodicals, Inc . 相似文献
130.
Seema Kalra Alan Silman Gulsen Akman-Demir Saeed Bohlega Afshin Borhani-Haghighi Cris S. Constantinescu Habib Houman Alfred Mahr Carlos Salvarani Petros P. Sfikakis Aksel Siva Adnan Al-Araji 《Journal of neurology》2014,261(9):1662-1676
Neuro-Behçet’s disease (NBD) is one of the more serious manifestations of Behçet’s disease (BD), which is a relapsing inflammatory multisystem disease with an interesting epidemiology. Though NBD is relatively uncommon, being potentially treatable, neurologists need to consider it in the differential diagnosis of inflammatory, infective, or demyelinating CNS disorders. Evidence-based information on key issues of NBD diagnosis and management is scarce, and planning for such studies is challenging. We therefore initiated this project to develop expert consensus recommendations that might be helpful to neurologists and other clinicians, created through an extensive literature review and wide consultations with an international advisory panel, followed by a Delphi exercise. We agreed on consensus criteria for the diagnosis of NBD with two levels of certainty in addition to recommendations on when to consider NBD in a neurological patient, and on the use of various paraclinical tests. The management recommendations included treatment of the parenchymal NBD and cerebral venous thrombosis, the use of disease modifying therapies, prognostic factors, outcome measures, and headache in BD. Future studies are needed to validate the proposed criteria and provide evidence-based treatments. 相似文献